Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Researchers investigate safety of convalescent plasma for COVID-19

The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.

17 May 2020

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.

17 May 2020

New algorithm could help investigate the genetic clues behind immunity

Scientists with UC San Diego's Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients - information that is key to creating a versatile and effective vaccine.

15 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Study confirms low prevalence of COVID-19 virus in Estonia

The results of a study conducted by the University of Tartu on the prevalence of the coronavirus were presented to the Government Committee responsible for the emergency situation on Tuesday.

15 May 2020

Sociodemographic factors linked to positive SARS-CoV-2 test result in primary care

Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.

15 May 2020

UCI partners with Orange County Health Care Agency for large-scale COVID-19 infection survey

It's almost certain that COVID-19 cases across the nation have been vastly undercounted, since people with few to no symptoms - who may be infected but have immunity - are rarely tested.

15 May 2020

Serological assays for SARS-CoV-2 can guide reintroduction of workforce if used with caution

With several high-quality serological assays for SARS-CoV-2 now available, the key challenge in using them to help people return to "normal life," write Florian Krammer and Viviana Simon in this Perspective, will be to apply them in a strategic manner - one that considers their unique sensitivity and specificity levels, acknowledges the questions they don't yet answer, and more.

15 May 2020

Developing a COVID-19 antigen test

News-Medical speaks to Alastair Smith, the CEO of Avacta, about the process behind their newly developed antigen test for COVID-19.

From Avacta Life Sciences Ltd. 15 May 2020

ChIP kits for high throughput antibody validation

Porvair Sciences report how its Chromatrap® ChIP kits provide an outstanding solution for antibodies suppliers looking to validate the performance of the antibodies they produce for chromatin immunoprecipitation (ChIP) assay kits.

From Porvair Sciences Limited 15 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

First cellular immunology data to help guide social distancing recommendations

Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available.

15 May 2020

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.

15 May 2020

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Boehringer Ingelheim and CDR-Life today announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic atrophy (GA).

From Boehringer Ingelheim International GmbH 15 May 2020

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

Novel study tracks symptomatic and asymptomatic COVID-19 spread in pediatric dialysis unit

As COVID-19 continues its sweep around the globe, dialysis units have continued to be hotspots for the virus' spread. Researchers at Indiana University School of Medicine hope to combat that threat, through a novel study published May 14, 2020 in JAMA.

14 May 2020

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

The country's first convalescent plasma transfusion trial results have been published and show 19 out of 25 patients improved with the treatment, and 11 were discharged from the hospital.

13 May 2020

Vaccine design can face specific challenges, say researchers

The goal of a vaccine is to trigger a response that safely protects against an infection and/or the burden of disease.

13 May 2020

Quest and Ortho Clinical Diagnostics join forces to expand COVID-19 antibody testing

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics, the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S.

13 May 2020

Antibody News and Research

Further Reading

Researchers investigate safety of convalescent plasma for COVID-19

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

New algorithm could help investigate the genetic clues behind immunity

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Study confirms low prevalence of COVID-19 virus in Estonia

Sociodemographic factors linked to positive SARS-CoV-2 test result in primary care

UCI partners with Orange County Health Care Agency for large-scale COVID-19 infection survey

Serological assays for SARS-CoV-2 can guide reintroduction of workforce if used with caution

Developing a COVID-19 antigen test

ChIP kits for high throughput antibody validation

Chasing the elusive dream of a COVID cure

First cellular immunology data to help guide social distancing recommendations

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

HVTN and HPTN initiate first clinical trial in response to COVID-19

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Novel study tracks symptomatic and asymptomatic COVID-19 spread in pediatric dialysis unit

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Vaccine design can face specific challenges, say researchers

Quest and Ortho Clinical Diagnostics join forces to expand COVID-19 antibody testing

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo